Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2019-04-12 | Willie A. Deese, Independent, Age 63, Director since 2011, Board Committees: HR (Chair), 2018 Director Compensation: $272,500 |
2020-04-07 | Willie A. Deese, Independent, Age 64, Director since 2011, Board Committees: Human Resources Committee (Chair), 2019 Director Compensation: $283,750 total. |
2021-04-16 | Mr. Deese retired from Merck & Co., Inc., a global pharmaceutical company, on June 1, 2016 after serving as Executive Vice President since 2008 and President of the Merck Manufacturing Division since 2005. He was also a member of Merck’s Executive Committee. Mr. Deese originally joined Merck in 2004 as the company’s Senior Vice President of Global Procurement. Formerly, Mr. Deese served as a member of the Board of Trustees of North Carolina A&T State University from 2007 to 2015. In addition, Mr. Deese served as the Chair of the Board of Trustees of North Carolina A&T State University from 2011 to 2013. Previously, Mr. Deese served as Senior Vice President of Global Procurement and Logistics at GlaxoSmithKline and as Senior Vice President of Procurement at SmithKlineBeecham. He serves on the Board of Directors for CDK Global Inc. as Chair of its Compensation Committee, on the Board of Directors of the Public Service Enterprise Group, Inc. as Chair of its Corporate Governance Committee, a member of its Compensation Committee and as a member of its Audit Committee and on the Board of Directors of G1 Therapeutics, Inc. as a member of its Audit Committee. |
2022-04-13 | Mr. Deese retired from Merck & Co., Inc., a global pharmaceutical company, on June 1, 2016 after serving as Executive Vice President since 2008 and President of the Merck Manufacturing Division since 2005. He was also a member of Merck's Executive Committee. Mr. Deese originally joined Merck in 2004 as the company's Senior Vice President of Global Procurement. Formerly, Mr. Deese served as a member of the Board of Trustees of North Carolina A&T State University from 2007 to 2015. In addition, Mr. Deese served as the Chair of the Board of Trustees of North Carolina A&T State University from 2011 to 2013. Previously, Mr. Deese served as Senior Vice President of Global Procurement and Logistics at GlaxoSmithKline and as Senior Vice President of Procurement at SmithKlineBeecham. He serves on the Board of Directors for CDK Global Inc. as Chair of its Compensation Committee, on the Board of Directors of the Public Service Enterprise Group, Inc. as Chair of its Corporate Governance Committee, a member of its Compensation Committee and as a member of its Audit Committee and on the Board of Directors of G1 Therapeutics, Inc. as a member of its Audit Committee. |
2023-04-14 | Mr. Deese retired from Merck & Co., Inc., a global pharmaceutical company, on June 1, 2016 after serving as Executive Vice President beginning in 2008 and President of the Merck Manufacturing Division beginning in 2005. He was also a member of Merck’s Executive Committee. Mr. Deese originally joined Merck in 2004 as the company’s Senior Vice President of Global Procurement. Formerly, Mr. Deese served as a member of the Board of Trustees of North Carolina A&T State University from 2007 to 2015. In addition, Mr. Deese served as the Chair of the Board of Trustees of North Carolina A&T State University from 2011 to 2013. Previously, Mr. Deese served as Senior Vice President of Global Procurement and Logistics at GlaxoSmithKline and as Senior Vice President of Procurement at SmithKlineBeecham. He serves on the Board of Directors of the Public Service Enterprise Group, Inc. as Chair of its Corporate Governance Committee, a member of its Compensation Committee and as a member of its Audit Committee. |
2024-04-10 | Willie A. Deese Independent Age: 68 Board Committees: • Human Resources Committee (Chair) Other Public Company Boards: • Public Service Enterprise Group, Inc. Mr. Deese retired from Merck & Co., Inc., a global pharmaceutical company, on June 1, 2016 after serving as Executive Vice President since 2008 and President of the Merck Manufacturing Division since 2005. He was also a member of Merck’s Executive Committee. Mr. Deese originally joined Merck in 2004 as the company’s Senior Vice President of Global Procurement. Prior to joining Merck, Mr. Deese served as Senior Vice President of Global Procurement and Logistics at GlaxoSmithKline and as Senior Vice President of Procurement at SmithKlineBeecham. He serves on the Board of Directors of the Public Service Enterprise Group, Inc. as Chair of its Corporate Governance Committee, a member of its Compensation Committee and as a member of its Audit Committee. Previously, Mr. Deese served as a member of the Board of Trustees of North Carolina A&T State University from 2007 to 2015, as the Chair of the Board of Trustees of North Carolina A&T State University from 2011 to 2013, on the Board of Directors for CDK Global Inc. as Chair of its Compensation Committee, and on the Board of Directors of G1 Therapeutics, Inc. as a member of its Audit Committee. |
Filing Date | Source Excerpt |
---|---|
2016-03-14 | Willie A. Deese Age: 60 Director since: 2016 Committees: Corporate Governance Organization & Compensation |
2017-03-14 | Willie A. Deese Age: 61 Director since: 2016 Occupation: Retired EVP-Merck & Co. Inc. Committees: Corporate Governance, Organization and Compensation Director Compensation Table: 243,196 USD |
2018-03-13 | Willie A. Deese Age: 62 Director since: 2016 Occupation: Retired EVP- Merck Co. Inc. Committees: Audit Corporate Governance Organization & Compensation |
2019-03-12 | Willie A. Deese, 63, Independent Director, Committees: A, CG, O, Compensation: $290,043 |
2020-03-16 | Audit Committee: Chair: Susan Tomasky; Members: Willie A. Deese, William V. Hickey, David Lilley, Barry H. Ostrowsky, Alfred W. Zollar ... Organization and Compensation Committee: Chair: David Lilley; Members: Willie A. Deese, Shirley Ann Jackson, Barry H. Ostrowsky, John P. Surma, Richard J. Swift, Susan Tomasky ... Director Compensation Table shows Willie A. Deese total compensation as $290,168. |
2021-03-15 | Willie A. Deese 65 2016 Retired Executive Vice President (EVP) of Merck & Co. Inc. ● A, CG (Chair), O |
2022-03-10 | Willie A. Deese, Retired EVP of Merck & Co. Inc., Age: 66, Director since: 2016. Committees: Audit, Corporate Governance (Chair), Organization and Compensation. Director Compensation Table shows total compensation of $305,152. |
2023-03-09 | WILLIE A. DEESE Retired EVP, Merck & Co. Inc. and President, Merck Manufacturing Division Age: 67 Director since: 2016 Committees Audit; Governance, Nominating and Sustainability (Chair); Organization and Compensation |
2024-03-07 | WILLIE A. DEESE Retired EVP, Merck & Co. Inc. and President, Merck Manufacturing Division Age: 68 Director since: 2016 Committees Audit; Executive; Governance, Nominating and Sustainability (Chair); Organization and Compensation Current Public Company Directorships Dentsply Sirona USA Prior Public Company Directorships CDK Global, Inc.; G1 Therapeutics, Inc. |
2025-03-13 | WILLIE A. DEESE Retired EVP, Merck & Co. Inc. and President, Merck Manufacturing Division Age: 69 Director since: 2016 Committees Audit; Executive; Governance, Nominating and Sustainability (Chair); Organization and Compensation Current Public Company Directorships Dentsply Sirona USA Prior Public Company Directorships CDK Global, Inc.; G1 Therapeutics, Inc. Experience Director of PSE&G (wholly owned subsidiary of PSEG) since December 2023. EVP of Merck & Co. Inc., which develops, manufactures and distributes pharmaceuticals, from January 2008 until June 2016, President of Merck Manufacturing Division from 2005 until 2008, and SVP of Global Procurement at Merck from 2004 to 2005. Prior to that, SVP of Global Procurement and Logistics at GlaxoSmithKline, a pharmaceutical company. Education MBA – Western New England University; BA – Business Administration, North Carolina A&T State University Reasons for Nomination Significant regulatory, manufacturing and procurement experience gained through his service as EVP of Merck & Co., President of Merck Manufacturing Division and SVP of Global Procurement and Logistics at GlaxoSmithKline. Thorough understanding of the many regulatory requirements our Company faces gained through extensive leadership experience in a highly-regulated industry. In-depth knowledge of human capital management and workplace culture. Deep knowledge of manufacturing and technology contributes to strong oversight of our operations and overall cost effectiveness. |
Data sourced from SEC filings. Last updated: 2025-10-11